JP2014509860A5 - - Google Patents

Download PDF

Info

Publication number
JP2014509860A5
JP2014509860A5 JP2013558453A JP2013558453A JP2014509860A5 JP 2014509860 A5 JP2014509860 A5 JP 2014509860A5 JP 2013558453 A JP2013558453 A JP 2013558453A JP 2013558453 A JP2013558453 A JP 2013558453A JP 2014509860 A5 JP2014509860 A5 JP 2014509860A5
Authority
JP
Japan
Prior art keywords
antibody
antibody according
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558453A
Other languages
English (en)
Japanese (ja)
Other versions
JP6220675B2 (ja
JP2014509860A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/054629 external-priority patent/WO2012123562A1/en
Publication of JP2014509860A publication Critical patent/JP2014509860A/ja
Publication of JP2014509860A5 publication Critical patent/JP2014509860A5/ja
Application granted granted Critical
Publication of JP6220675B2 publication Critical patent/JP6220675B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558453A 2011-03-16 2012-03-16 診断用抗体アッセイ Expired - Fee Related JP6220675B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161453449P 2011-03-16 2011-03-16
US61/453,449 2011-03-16
PCT/EP2012/054629 WO2012123562A1 (en) 2011-03-16 2012-03-16 Diagnostic antibody assay

Publications (3)

Publication Number Publication Date
JP2014509860A JP2014509860A (ja) 2014-04-24
JP2014509860A5 true JP2014509860A5 (https=) 2015-04-23
JP6220675B2 JP6220675B2 (ja) 2017-11-01

Family

ID=45833428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013558453A Expired - Fee Related JP6220675B2 (ja) 2011-03-16 2012-03-16 診断用抗体アッセイ

Country Status (15)

Country Link
US (2) US8809508B2 (https=)
EP (1) EP2686346B1 (https=)
JP (1) JP6220675B2 (https=)
KR (1) KR102020072B1 (https=)
CN (1) CN103459421B (https=)
AU (1) AU2012228236B2 (https=)
BR (1) BR112013023211B1 (https=)
CA (1) CA2828433C (https=)
DK (1) DK2686346T3 (https=)
EA (1) EA032054B1 (https=)
IL (1) IL227847A0 (https=)
MX (1) MX343873B (https=)
SG (1) SG192805A1 (https=)
WO (1) WO2012123562A1 (https=)
ZA (1) ZA201305946B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9512115B2 (en) 2013-03-15 2016-12-06 Probiodrug Ag Inhibitors
WO2016097305A1 (en) 2014-12-19 2016-06-23 Probiodrug Ag Novel method for the detection of pglu-abeta peptides
US10494425B2 (en) * 2015-02-24 2019-12-03 Rpeptide, Llc Anti-amyloid-beta antibodies
IL256579B2 (en) * 2015-07-16 2023-03-01 Probiodrug Ag Human antibodies
GB201910697D0 (en) * 2019-07-26 2019-09-11 Binding Site Group Ltd Lonisation control
US20210096128A1 (en) * 2019-10-01 2021-04-01 Repligen Corporation Determination of protein concentration in a fluid
KR102790945B1 (ko) * 2022-09-23 2025-04-04 경성대학교 산학협력단 베타-아밀로이드 42를 이용한 치매 진단 방법 및 이를 이용한 치매 진단 키트
CN121253823A (zh) * 2025-10-10 2026-01-02 山东九嘉生物科技有限公司 一种用于检测胃蛋白酶原ⅰ的化学发光试剂盒及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
ES2275570T3 (es) * 1999-12-08 2007-06-16 Intellect Neurosciences, Inc. Peptidos amiloides beta quimericos.
US7117096B2 (en) * 2001-04-17 2006-10-03 Abmaxis, Inc. Structure-based selection and affinity maturation of antibody library
CA2487528A1 (en) 2002-07-24 2004-02-12 Innogenetics N.V. Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
WO2004029629A1 (en) 2002-09-27 2004-04-08 Janssen Pharmaceutica N.V. N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
US7304086B2 (en) 2004-02-05 2007-12-04 Probiodrug Ag Inhibitors of glutaminyl cyclase
ES2259270B1 (es) 2005-03-09 2007-11-01 Consejo Superior De Investigaciones Cientificas Metodo de diagnostico in vitro de la enfermedad de alzheimer mediante un anticuerpo monoclonal.
US20100028351A1 (en) 2006-06-29 2010-02-04 Marc Mercken Anti-amyloid antibodies, compositions, methods and uses
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
JP5599614B2 (ja) 2006-11-09 2014-10-01 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
EP2091945B1 (en) 2006-11-09 2014-01-15 Probiodrug AG Novel inhibitors of glutaminyl cyclase
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
US7803810B2 (en) 2007-03-09 2010-09-28 Probiodrug Ag Inhibitors
WO2008128983A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
WO2008128982A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors
JP5675340B2 (ja) 2007-04-18 2015-02-25 プロビオドルグ エージー 新規阻害剤
JP5675343B2 (ja) 2007-04-18 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としての尿素誘導体
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
JP5676249B2 (ja) 2007-04-20 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体
EP2211886A4 (en) * 2007-10-15 2011-07-27 Centocor Ortho Biotech Inc HUMAN ANTI-AMYLOID ANTIBODIES, COMPOSITIONS, PROCESSES AND APPLICATIONS
AT506820B1 (de) * 2008-06-12 2011-07-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzine gegen alzheimer-krankheit
EP2320942B1 (en) * 2008-07-21 2018-03-14 Probiodrug AG Diagnostic antibody assay
WO2010128139A1 (en) * 2009-05-08 2010-11-11 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Biomarkers and methods for diagnosing alzheimer's disease and/ or mild cognitive impairment
PT2448968T (pt) * 2009-06-29 2021-04-30 Bioarctic Ab ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL

Similar Documents

Publication Publication Date Title
JP2014509860A5 (https=)
JP2011528561A5 (https=)
KR101982899B1 (ko) TL1a에 대한 항체 및 그의 용도
CA2861793C (en) Method of providing monoclonal auto-antibodies with desired specificity
JP2016516400A5 (https=)
JP2013506428A5 (https=)
JP2009518005A5 (https=)
JP2015535820A5 (https=)
RS53270B2 (sr) Monoklonalna antitela protiv amiloidnog beta proteina i njihova upotreba
IL186948A0 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
HRP20191342T1 (hr) Anti-phf-tau antitijela i njihove upotrebe
JP2011511624A5 (https=)
JP2016020389A5 (https=)
JP2010536384A5 (https=)
JP2014518883A5 (https=)
JP2011173884A5 (https=)
JP2016531546A5 (https=)
JP2013520174A5 (https=)
JP2013542914A5 (https=)
JP2013539369A5 (https=)
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
WO2014106235A1 (en) Anti-granulysin antibodies and methods of use thereof
RU2014106933A (ru) Способы и композиции для лечения аутоиммунных и воспалительных заболеваний
RU2017139800A (ru) Комбинированный препарат антител против staphylococcus aureus
JP2018507254A5 (https=)